Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. - Wikidata - awgldk - TriplyDB

Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan.

Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan.

http://www.wikidata.org/entity/Q43277024

about

Second and third line treatment options for Helicobacter pylori eradication Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations.Treatment of Helicobacter pylori infection: current status and future concepts.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy.High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Treatment for Eradication of Helicobacter pylori Infection among Chronic Hepatitis C Patients.Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days.Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran.Association of helicobacter pylori dupA with the failure of primary eradication The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea.Antibiotics resistance rate of Helicobacter pylori in Bhutan Review article: the global emergence of Helicobacter pylori antibiotic resistance.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies.Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea.Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy.Real-Time PCR detection and quantitation of Helicobacter pylori clarithromycin-resistant strains in archival material and correlation with Sydney classification Cost-Effectiveness Analysis of Helicobacter pylori Diagnostic Methods in Patients with Atrophic Gastritis.Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype.Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication.Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis.Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Biofilms and Helicobacter pylori: Dissemination and persistence within the environment and host.Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection.Gastroprotective effect of minocycline in experimentally induced gastric ulcers in rats Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.Fucoidans Disrupt Adherence of Helicobacter pylori to AGS Cells In Vitro.Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.Rabeprazole, Minocycline, Amoxicillin, and Bismuth as First-Line and Second-Line Regimens for Helicobacter pylori Eradication.Esomeprazole, minocycline, metronidazole and bismuth as first-line and second-line regimens for Helicobacter pylori eradication.Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.Biofilm Formation by Helicobacter pylori and Its Involvement for Antibiotic Resistance Ultimate eradication rate of Helicobacter pylori after first, second, or third-line therapy in Korea.In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.

P2860

Q26829666-5A1F8A33-8AB1-40AC-96A4-CC09D6659E1F Q30381104-6A127E38-AA0B-4A43-B7B0-18409B5BE923 Q31138535-5AF0B90C-6579-4DED-81E7-9C4A42C99DA5 Q33594850-CBC2C386-D741-4A64-AF9C-8304C0E86E17 Q33639114-CD038A72-F500-4D39-BC75-E6E18F235B5F Q33766917-43812BA1-93C6-44EE-8E31-E2BD66BE92A6 Q33893567-D22C816A-7A0D-4715-8A83-6FFC874A98B5 Q34190303-8074F012-510C-449B-B1A0-B7737EB87900 Q34314718-17D65452-7138-4EF9-975E-44521642BAA4 Q35598058-E5B588E4-EADA-43CD-9A4C-CF3434965D2B Q35619151-E0A66804-5E47-42DB-99DE-46A933BD717F Q35632640-C7E3CA5A-54D4-4D18-9786-BF7790461C4B Q35744435-FEE71D4A-3628-4FD2-B838-C33DE670A34C Q35812798-2CE84798-2B35-46AF-B4CE-9BE28F91A975 Q36565896-2988557E-AC9B-47D5-9836-57C19DDCB99F Q37060060-92F666C1-FD4E-48A8-A0F3-D9287E55F008 Q37142225-59154B42-917C-4A27-BBF7-0647894600E6 Q37340339-B7C3D497-7F6A-49A4-A916-4D7007F30A33 Q37378899-B9FE52C6-BCD0-4532-9479-8E8AC7990676 Q37533456-69561B0B-503D-417D-8132-E4D2FBD780E0 Q37587260-8E77AB90-C761-4B81-8594-149C436F52E7 Q37625226-EA0E28B9-3996-4DE8-A2F6-46A02C618FE4 Q37647472-22D0CC7F-DF1B-4C3F-AFCD-491992EBB343 Q37694256-BBE0B989-F762-4D27-8F9F-C6F6CDAD42A0 Q37724709-602203B0-B192-4D7B-9068-D1024361E324 Q38029324-0BC9ED23-8F33-42CB-BDB0-8E87BDD418FE Q38194611-978D0E53-74EE-4BFF-8172-777D0A56CDA6 Q38238745-201C762D-9E56-4C7A-A4F3-8B9BF3BA9CE8 Q38240874-23651FF3-18F4-47F5-B5C5-997150839A5D Q38621376-EED69435-B9E1-4775-B57B-80135968DE00 Q38837426-56D4EDF7-9794-4BB0-8644-9257BFAE07CF Q39503264-0F7E7929-69E6-4B32-8513-34DBD3993403 Q40277561-EC22F4A2-F144-4BE2-B189-496C9D4B6096 Q40572311-D8BB3D76-5CD6-4DB1-8C51-2BAE22F4BE91 Q40722225-80A70538-5D60-4C8B-89FF-36F0C095822B Q40766383-D780CDE1-6D22-41B4-9139-A75903D7CE4C Q41121067-AD6EF5CD-06CC-4863-A965-8EAF73286C62 Q41158525-14B295F6-5B94-4655-A7F6-F4D783701F6F Q41680509-E0294CA9-488E-4DA3-91B4-42F168759DB3 Q42958346-7E66EDE1-786C-4C1B-B881-421B40DB670A

P2860

Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan.

http://www.wikidata.org/entity/Q43277024

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Annual change of primary resis ...... om 1996 through 2008 in Japan.

@en

Annual change of primary resis ...... om 1996 through 2008 in Japan.

@nl

type

label

Annual change of primary resis ...... om 1996 through 2008 in Japan.

@en

Annual change of primary resis ...... om 1996 through 2008 in Japan.

@nl

prefLabel

Annual change of primary resis ...... om 1996 through 2008 in Japan.

@en

Annual change of primary resis ...... om 1996 through 2008 in Japan.

@nl

P1433

Q43277024-21EB5281-931F-40E1-8E63-A708D660861B

P1476

Q43277024-B8260E15-C122-4308-BE31-85E1D2BE30F7

P2093

Q43277024-0C734A28-8DC4-4FDA-842A-A5E273258048

Q43277024-1759E284-216D-4532-9BA8-F9CBF6FF05E8

Q43277024-3C3FFEBA-2BC7-4260-AA06-8A87A64F4AE8

Q43277024-71ACA1EE-6F41-4ABF-AFDA-9164C60FB033

Q43277024-95A6EB54-F330-49F4-867D-6F8D8C85BBD1

Q43277024-9F16E45A-3BF0-463F-BF6A-231ACD2C0463

Q43277024-B6FB0CAF-70A4-436C-87FE-0A470D1701E2

Q43277024-BD09F008-73BA-4A5B-98AE-B28C12E9F9AA

Q43277024-E7558943-3867-4D05-93B5-045D06BEAE1E

Q43277024-E8E1C5F1-F277-447E-BE53-B45FD2DED61E

P2860

Q43277024-B947F252-DA8D-4DF2-8A32-AA8951A50800

P304

Q43277024-B2DB86B1-0FBE-4546-8D08-A00EA0C2BA23

P31

Q43277024-D46B0F4E-D3CB-4C88-95EF-183B43805998

P356

Q43277024-BF7075C9-9EF6-4AC2-8E62-47B4C37CCA40

P433

Q43277024-5905FDFC-243D-408A-ACD7-142A5B520CE1

P478

Q43277024-4B29FC87-6A53-4B9E-A039-EE8ACE691EF5

P577

Q43277024-4E15EAF2-42B1-41B1-B6FA-8CFAE9C04F6C

P698

Q43277024-6D5E9318-D3A5-4525-9764-72D19DF14748

P921

Q43277024-DF8EEF72-DD29-468D-99CE-EF4386AE3197

P356

J.1523-5378.2009.00714.X

P1433

P1476

Annual change of primary resis ...... om 1996 through 2008 in Japan.

@en

P2093

Fumio Omata

http://www.w3.org/2001/XMLSchema#string

Gabazza Esteban Cesar

http://www.w3.org/2001/XMLSchema#string

Ichiro Imoto

http://www.w3.org/2001/XMLSchema#string

Katsuyuki Fukuda

http://www.w3.org/2001/XMLSchema#string

Masaki Katsurahara

http://www.w3.org/2001/XMLSchema#string

Masayo Uemura

http://www.w3.org/2001/XMLSchema#string

Naoki Ishii

http://www.w3.org/2001/XMLSchema#string

Noriyuki Horiki

http://www.w3.org/2001/XMLSchema#string

Shoko Suzuki

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

P304

86-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1523-5378.2009.00714.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19751432

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori